Mes compétences :
Capital risque
Biotechnologies
Microbiologie
Entreprises
Auriga Partners
- Life sciences Partner
PARIS2014 - maintenantAURIGA IV Bioseeds is a seed investment fund of more than €40M, supported by the Banque Publique d’Investissement, the European Investment Fund and several corporate investors among which Sanofi Pasteur and Pfizer. The fund is focusing on supporting technological companies emerging from knowledge and know-how developed in Infectiology and Microbiology.
Omnes Capital (ex-Crédit Agricole Private Equity)
- Directeur de participations
2011 - 2014Actively involved in VC investment activities in Europe.
Board member of Amakem (Belgium) and Complix (Belgium).
Observer on the boards of Flexgen and Medisse.
With 400M€ assets under management, Omnes Capital is a leading player in the venture capital market. It focuses on fast-growing innovative companies with strong international potential, run by talented entrepreneurs. The investment strategy covers all segments of the venture capital market, from seed stage through to later stages, and has interest in all life sciences sectors: drug development, diagnostics, biomanufacturing and medical device.
www.omnescapital.com
Omnes Capital (ex-Crédit Agricole Private Equity)
- Associate Life Sciences
2007 - 2011
Institut Pasteur
- Chercheur contractuel
Paris2003 - 2006Management of a fundamental research project on the immunosuppressive properties of a bacterial toxin.
International scientific publications in J. Exp. Med., Microbes Infect., Cell Microbiol., PLoS Negl Trop Dis.
